GLYC logo

GlycoMimetics (GLYC) EBITDA

Annual EBITDA

-$39.12 M
+$8.07 M+17.11%

December 31, 2023

Summary

Performance

1-Year Change

+17.11%

3-Year Change

+23.65%

5-Year Change

+23.64%

15-Year Change

-16.2%

GLYC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.65%
GLYC annual EBITDA is higher than 37.65% of companies in Healthcare sector

High & Low

All-time High

$3.73 M
GLYC annual EBITDA is currently -1147.46% below its historical high of $3.73 million

3-Year Low

-$63.18 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
GLYC previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 27, 2025
GLYC next annual earnings announcement is scheduled for Mar 27, 2025

OtherGLYCprofitabilitymetrics:

Annual Revenue

$10.00 K
GLYC annual revenue is $10.00 thousand

Annual Net Income

-$36.90 M
GLYC annual net profit is -$36.90 million

Annual EBIT

-$39.27 M
GLYC annual earnings before interest & taxes is -$39.27 million

Annual EPS

-$0.58
GLYC annual earnings per share is -$0.58

Quarterly EBITDA

-$5.71 M
+$4.63 M+44.77%

September 30, 2024

Summary

Performance

3-Month Change

+44.77%

1-Year Change

+40.28%

3-Year Change

+67.1%

5-Year Change

+67.1%

GLYC Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.17%
GLYC quarterly EBITDA is higher than 45.17% of companies in Healthcare sector

High & Low

All-time High

$10.43 M
GLYC quarterly EBITDA is currently -154.76% below its historical high of $10.43 million

3-Year Low

-$17.36 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
GLYC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
GLYC next earnings announcement is scheduled for Mar 27, 2025

OtherGLYCprofitabilitymetrics:

Quarterly Revenue

-
GLYC quarterly revenue value is unknown

Quarterly Net Income

-$9.82 M
GLYC quarterly net profit is -$9.82 million

Quarterly EBIT

-$5.72 M
GLYC quarterly earnings before interest & taxes is -$5.72 million

Quarterly EPS

-$0.15
GLYC quarterly earnings per share is -$0.15

TTM EBITDA

-$36.73 M
+$4.06 M+9.95%

September 30, 2024

Summary

Performance

3-Month Change

+9.95%

1-Year Change

+6.12%

3-Year Change

+41.87%

5-Year Change

+41.87%

GLYC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.71%
GLYC TTM EBITDA is higher than 37.71% of companies in Healthcare sector

High & Low

All-time High

$1.99 M
GLYC TTM EBITDA is currently -1949.36% below its historical high of $1.99 million

3-Year Low

-$63.57 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
GLYC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
GLYC next earnings announcement is scheduled for Mar 27, 2025

OtherGLYCprofitabilitymetrics:

TTM Revenue

-
GLYC TTM revenue value is unknown

TTM Net Income

-$39.73 M
GLYC TTM net profit is -$39.73 million

TTM EBIT

-$36.78 M
GLYC TTM earnings before interest & taxes is -$36.78 million

TTM EPS

-$0.62
GLYC TTM earnings per share is -$0.62

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$39.12 M
GLYC annual EBITDA is -$39.12 million

Annual Net Income

-$36.90 M
GLYC annual net profit is -$36.90 million

Annual Interest Expense

-
GLYC annual interest expense value is unknown

Annual Income Tax

-
GLYC annual income tax value is unknown

Annual D&A

$153.30 K
GLYC annual depreciation & amortization is $153.30 thousand

GLYC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.1%+40.3%+6.1%
3 y3 years+23.6%+67.1%+41.9%
5 y5 years+23.6%+67.1%+41.9%

GLYC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+38.1%at high+67.1%at high+42.2%
5 y5-yearat high+38.1%at high+67.1%at high+42.2%
alltimeall time-1147.5%+38.1%-154.8%+67.1%-1949.4%+42.2%

GlycoMimetics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.71 M(-44.8%)
-$36.73 M(-9.9%)
Jun 2024
-
-$10.35 M(-6.8%)
-$40.78 M(+3.7%)
Mar 2024
-
-$11.10 M(+16.0%)
-$39.33 M(+0.5%)
Dec 2023
-$39.12 M(-17.1%)
-$9.57 M(-2.1%)
-$39.12 M(-2.5%)
Sep 2023
-
-$9.77 M(+10.0%)
-$40.13 M(+2.7%)
Jun 2023
-
-$8.89 M(-18.5%)
-$39.08 M(-10.1%)
Mar 2023
-
-$10.90 M(+3.0%)
-$43.49 M(-7.8%)
Dec 2022
-$47.20 M(-25.3%)
-$10.58 M(+21.3%)
-$47.20 M(-12.6%)
Sep 2022
-
-$8.72 M(-34.4%)
-$53.98 M(-13.7%)
Jun 2022
-
-$13.30 M(-8.9%)
-$62.53 M(-1.6%)
Mar 2022
-
-$14.60 M(-15.9%)
-$63.57 M(+0.6%)
Dec 2021
-$63.18 M(+23.3%)
-$17.36 M(+0.6%)
-$63.18 M(+3.0%)
Sep 2021
-
-$17.27 M(+20.5%)
-$61.32 M(+6.3%)
Jun 2021
-
-$14.34 M(+0.9%)
-$57.71 M(+0.5%)
Mar 2021
-
-$14.21 M(-8.3%)
-$57.41 M(+12.0%)
Dec 2020
-$51.24 M(-16.2%)
-$15.50 M(+13.5%)
-$51.24 M(+0.5%)
Sep 2020
-
-$13.66 M(-2.7%)
-$51.01 M(-0.7%)
Jun 2020
-
-$14.04 M(+74.6%)
-$51.38 M(-5.0%)
Mar 2020
-
-$8.04 M(-47.3%)
-$54.09 M(-11.5%)
Dec 2019
-$61.11 M(+19.3%)
-$15.27 M(+8.8%)
-$61.11 M(+0.6%)
Sep 2019
-
-$14.04 M(-16.2%)
-$60.73 M(+2.7%)
Jun 2019
-
-$16.75 M(+11.2%)
-$59.15 M(+8.6%)
Mar 2019
-
-$15.06 M(+1.1%)
-$54.48 M(+6.4%)
Dec 2018
-$51.23 M
-$14.89 M(+19.6%)
-$51.23 M(+11.8%)
Sep 2018
-
-$12.45 M(+3.1%)
-$45.80 M(+10.5%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$12.08 M(+2.3%)
-$41.47 M(+18.3%)
Mar 2018
-
-$11.81 M(+24.7%)
-$35.04 M(+12.5%)
Dec 2017
-$33.67 M(+6.1%)
-$9.47 M(+16.7%)
-$31.15 M(+3.9%)
Sep 2017
-
-$8.11 M(+43.4%)
-$29.99 M(+0.9%)
Jun 2017
-
-$5.66 M(-28.6%)
-$29.72 M(-7.4%)
Mar 2017
-
-$7.92 M(-4.7%)
-$32.11 M(+1.2%)
Dec 2016
-$31.72 M(+151.9%)
-$8.31 M(+6.0%)
-$31.72 M(-1.6%)
Sep 2016
-
-$7.84 M(-2.6%)
-$32.25 M(+2.3%)
Jun 2016
-
-$8.05 M(+6.9%)
-$31.53 M(+141.6%)
Mar 2016
-
-$7.53 M(-14.8%)
-$13.05 M(+3.6%)
Dec 2015
-$12.59 M(+14.7%)
-$8.84 M(+24.1%)
-$12.59 M(+13.4%)
Sep 2015
-
-$7.12 M(-168.2%)
-$11.11 M(+4.3%)
Jun 2015
-
$10.43 M(-247.6%)
-$10.65 M(-18.0%)
Mar 2015
-
-$7.07 M(-3.9%)
-$12.98 M(+18.2%)
Dec 2014
-$10.98 M(+4.8%)
-$7.35 M(+10.4%)
-$10.98 M(+47.2%)
Sep 2014
-
-$6.66 M(-182.2%)
-$7.46 M(+66.9%)
Jun 2014
-
$8.10 M(-259.8%)
-$4.47 M(-72.1%)
Mar 2014
-
-$5.07 M(+32.3%)
-$16.04 M(+53.1%)
Dec 2013
-$10.47 M(-380.4%)
-$3.83 M(+4.5%)
-$10.47 M(+74.7%)
Sep 2013
-
-$3.67 M(+5.9%)
-$6.00 M(+305.6%)
Jun 2013
-
-$3.46 M(-806.1%)
-$1.48 M(-174.4%)
Mar 2013
-
$490.60 K(-23.8%)
$1.99 M(+32.8%)
Dec 2012
$3.73 M(-162.2%)
$644.10 K(-24.3%)
$1.50 M(+75.7%)
Sep 2012
-
$851.20 K
$851.20 K
Dec 2011
-$6.00 M
-
-

FAQ

  • What is GlycoMimetics annual EBITDA?
  • What is the all time high annual EBITDA for GlycoMimetics?
  • What is GlycoMimetics annual EBITDA year-on-year change?
  • What is GlycoMimetics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for GlycoMimetics?
  • What is GlycoMimetics quarterly EBITDA year-on-year change?
  • What is GlycoMimetics TTM EBITDA?
  • What is the all time high TTM EBITDA for GlycoMimetics?
  • What is GlycoMimetics TTM EBITDA year-on-year change?

What is GlycoMimetics annual EBITDA?

The current annual EBITDA of GLYC is -$39.12 M

What is the all time high annual EBITDA for GlycoMimetics?

GlycoMimetics all-time high annual EBITDA is $3.73 M

What is GlycoMimetics annual EBITDA year-on-year change?

Over the past year, GLYC annual EBITDA has changed by +$8.07 M (+17.11%)

What is GlycoMimetics quarterly EBITDA?

The current quarterly EBITDA of GLYC is -$5.71 M

What is the all time high quarterly EBITDA for GlycoMimetics?

GlycoMimetics all-time high quarterly EBITDA is $10.43 M

What is GlycoMimetics quarterly EBITDA year-on-year change?

Over the past year, GLYC quarterly EBITDA has changed by +$3.85 M (+40.28%)

What is GlycoMimetics TTM EBITDA?

The current TTM EBITDA of GLYC is -$36.73 M

What is the all time high TTM EBITDA for GlycoMimetics?

GlycoMimetics all-time high TTM EBITDA is $1.99 M

What is GlycoMimetics TTM EBITDA year-on-year change?

Over the past year, GLYC TTM EBITDA has changed by +$2.39 M (+6.12%)